EYEN - アイノビア (Eyenovia Inc.) アイノビア

 EYENのチャート


 EYENの企業情報

symbol EYEN
会社名 Eyenovia Inc (アイノビア)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   アイノビアは米国のバイオ医薬品メ―カ―。主に眼科用医薬品の開発・商業化に注力する。同社の主な候補薬には、慢性閉塞隅角緑内障の治療薬「MicroProst」、散瞳の治療を対象とする「MicroStat」、ドライアイ治療薬の「MicroTears」、近視治療薬「MicroPine」などがある。本社所在地はニューヨーク。   Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.
本社所在地 501 Fifth Avenue Suite 1404 New York NY 10017 USA
代表者氏名
代表者役職名
電話番号
設立年月日 41699
市場名 NASDAQ Small Cap
ipoyear 2018年
従業員数
url www.eyenoviabio.com
nasdaq_url https://www.nasdaq.com/symbol/eyen
adr_tso
EBITDA EBITDA ー
終値(lastsale) 3.97
時価総額(marketcap) 39694624.62
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 EYENのテクニカル分析


 EYENのニュース

   Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q4 2021 Results - Earnings Call Transcript  2022/03/29 02:13:03 Seeking Alpha
   Eyenovia GAAP EPS of $0.10 beats by $0.32, revenue of $10M  2022/03/28 20:13:09 Seeking Alpha
Eyenovia press release (EYEN): Q4 GAAP EPS of $0.10 beats by $0.32.Revenue of $10M (+400.0% Y/Y).As of December 31, 2021, the Company’s cash and cash equivalents were approximately…
   Eyenovia Reports Fourth Quarter and Full Year 2021 Financial Results  2022/03/28 20:05:00 GlobeNewswire
Successfully completed Type A meeting with FDA and anticipates MydCombi™ NDA resubmission in Q3 2022
   Eyenovia Raises 15M Via Equity To Advance MydCombi Program  2022/03/04 14:07:56 Benzinga
Eyenovia Inc (NASDAQ: EYEN ) has entered into a Securities Purchase Agreement with Armistice Capital Master Fund Ltd for gross proceeds of $15 million . The offering includes 3 million shares, pre-funded warrants to purchase up to 1.87 million shares, and common warrants to purchase up to 4.87 million shares. The aggregate offering price for each share of … Full story available on Benzinga.com
   Eyenovia receives $15M institutional capital investment from Armistice Capital  2022/03/04 12:44:29 Seeking Alpha
Eyenovia (EYEN) trades 2.3% down premarket after it entered into a securities purchase agreement with Armistice Capital Master Fund in an offering of 3M shares of its common…
   Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation  2021/06/02 10:10:14 Seeking Alpha
   Chasing Allergan, Eyenovia hits endpoint in vision phase 3  2021/05/28 07:46:30 FiercePharma
Chasing Allergan, Eyenovia hits endpoint in vision phase 3 ntaylor Fri, 05/28/2021 - 03:46
   Eyenovia (EYEN) Gets a Buy Rating from Northland Securities  2021/05/26 14:00:17 Smarter Analyst
Northland Securities analyst Tim Chiang maintained a Buy rating on Eyenovia (EYEN) yesterday and set a price target of $12.00. The post Eyenovia (EYEN) Gets a Buy Rating from Northland Securities appeared first on Smarter Analyst .
   Eyenovia Stock Shoots Higher on Positive MicroLine Data in Late-Stage Presbyopia Study  2021/05/25 15:18:54 Benzinga
Eyenovia Inc (NASDAQ: EYEN ) has announced topline data from its VISION-1 Phase 3 study evaluating MicroLine, for the temporary improvement of near vision in adults with presbyopia. The results will be presented at a future ophthalmic-focused medical meeting. The study met its primary endpoint with a statistically significant proportion of subjects treated with MicroLine showing Full story available on Benzinga.com
   Stock Alert: Eyenovia Up 10% On Positive Late-stage Study Results Of Its MicroLine  2021/05/25 14:12:32 RTT News
Shares of Eyenovia, Inc. (EYEN) are rising more than 10% Tuesday morning after the company announced positive top line results from the late-stage study of MicroLine for the treatment of Presbyopia.
   Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation  2021/06/02 10:10:14 Seeking Alpha

 関連キーワード  (― 米国株 アイノビア EYEN Eyenovia Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)